share_log

Kymera Therapeutics(KYMR.US) Director Sells US$5.13 Million in Common Stocks

moomoo News ·  Mar 15 20:05

$Kymera Therapeutics (KYMR.US)$ Director Booth Bruce sold 127.54K shares of Common Stocks on Mar 14, 15, 2024 at an average price of $40.25 for a total value of $5.13 million.

1710547519698523411.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment